Huahaipharm: Carboxymethyl Sodium Injection has obtained a drug registration certificate
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Huahai Pharmaceutical announced that the company recently received the "Drug Registration Certificate" for Carbetocin Injection issued by the National Medical Products Administration. Carbetocin Injection is used for bleeding diseases in the urinary system, upper digestive tract, respiratory tract, and obstetrics and gynecology, showing significant efficacy in the urinary system, and can also be used for the prevention and treatment of surgical bleeding, among other uses
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments